HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric Hachulla Selected Research

beta-cyclodextrin tetradecasulfate (CTDS)

1/2018Undifferentiated connective tissue disease: state of the art on clinical practice guidelines.
12/2013Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension.
1/2011Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric Hachulla Research Topics

Disease

39Systemic Scleroderma (Systemic Sclerosis)
11/2021 - 12/2002
19Autoimmune Diseases (Autoimmune Disease)
10/2022 - 12/2002
13Vasculitis (Vasculitides)
01/2022 - 09/2011
13Interstitial Lung Diseases (Interstitial Lung Disease)
11/2021 - 06/2008
13Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 03/2004
12Infections
12/2021 - 05/2008
10Myositis (Idiopathic Inflammatory Myopathies)
01/2022 - 06/2009
9Fibrosis (Cirrhosis)
11/2022 - 01/2004
9Neoplasms (Cancer)
11/2021 - 05/2009
9Fatigue
11/2021 - 06/2011
8Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
05/2022 - 08/2006
8Connective Tissue Diseases (Connective Tissue Disease)
05/2022 - 12/2006
7Rheumatoid Arthritis
06/2021 - 05/2009
7Microscopic Polyangiitis
12/2020 - 10/2006
7Fever (Fevers)
01/2019 - 01/2002
7Pain (Aches)
01/2017 - 12/2007
6Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2022 - 10/2006
6Antisynthetase syndrome
01/2021 - 12/2012
6Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
12/2020 - 11/2014
6Pulmonary Arterial Hypertension
01/2020 - 05/2008
6Rheumatic Diseases (Rheumatism)
01/2018 - 07/2010
5Inflammation (Inflammations)
11/2022 - 01/2015
5Cardiovascular Diseases (Cardiovascular Disease)
10/2022 - 12/2007
5Thrombosis (Thrombus)
05/2022 - 07/2006
5Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2018 - 03/2011
5digital ulcers
01/2018 - 04/2006
5Pulmonary Hypertension
11/2017 - 01/2004
4Cryopyrin-Associated Periodic Syndromes
11/2022 - 05/2006
4Proteinuria
11/2022 - 12/2002
4Hemorrhage
07/2022 - 07/2006
4Arthralgia (Joint Pain)
01/2022 - 05/2006
4Disease Progression
01/2022 - 01/2002
4Amyloidosis
10/2020 - 12/2002
4Sjogren's Syndrome (Sjogren Syndrome)
01/2020 - 06/2011
4Necrosis
12/2018 - 03/2007
3Immunoglobulin G4-Related Disease
05/2022 - 01/2017
3Musculoskeletal Diseases (Musculoskeletal Disease)
01/2022 - 06/2021
3Joint Diseases (Joint Disease)
01/2022 - 06/2010
3Arthritis (Polyarthritis)
07/2021 - 05/2015
3Churg-Strauss Syndrome (Allergic Angiitis)
12/2020 - 08/2015
3Mononeuropathies (Mononeuritis Multiplex)
10/2020 - 09/2004
3Capillary Leak Syndrome
05/2020 - 07/2008
3Dermatomyositis (Dermatopolymyositis)
01/2019 - 06/2009
3Castleman Disease (Castleman's Disease)
01/2019 - 01/2014
3Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2019 - 06/2010
3Polymyositis
12/2018 - 06/2009
3Rare Diseases (Rare Disease)
01/2018 - 09/2012
3Paraproteinemias (Monoclonal Gammopathy)
10/2014 - 07/2009
3Neurologic Manifestations (Neurological Manifestations)
02/2014 - 03/2004
3Systemic Vasculitis
01/2013 - 10/2006
3Multiple Sclerosis
03/2012 - 03/2004
2Neonatal Systemic lupus erythematosus
10/2022 - 12/2015

Drug/Important Bio-Agent (IBA)

29AntibodiesIBA
10/2022 - 03/2004
18Rituximab (Mabthera)FDA Link
06/2021 - 01/2006
17Biological ProductsIBA
05/2022 - 01/2002
14Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2022 - 10/2006
13AutoantibodiesIBA
02/2020 - 03/2004
12Adrenal Cortex Hormones (Corticosteroids)IBA
06/2021 - 04/2006
9Immunoglobulins (Immunoglobulin)IBA
05/2022 - 05/2008
9SteroidsIBA
01/2021 - 04/2005
7Biomarkers (Surrogate Marker)IBA
05/2022 - 12/2007
7C-Reactive ProteinIBA
04/2019 - 06/2002
7Immunoglobulin G (IgG)IBA
01/2019 - 03/2004
7Proteins (Proteins, Gene)FDA Link
07/2018 - 12/2002
6Immunosuppressive Agents (Immunosuppressants)IBA
01/2022 - 11/2009
6Hydroxychloroquine (Plaquenil)FDA LinkGeneric
12/2021 - 01/2002
6Pharmaceutical PreparationsIBA
01/2021 - 05/2009
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2020 - 09/2004
5GlucocorticoidsIBA
01/2022 - 11/2014
5ametantrone (HAQ)IBA
10/2020 - 06/2015
5Carbon MonoxideIBA
01/2019 - 01/2009
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2017 - 09/2009
4AA amyloidosisIBA
11/2022 - 05/2006
4Antirheumatic Agents (DMARD)IBA
01/2022 - 12/2017
4CreatinineIBA
01/2020 - 04/2010
4Ligases (Synthetase)IBA
12/2018 - 06/2011
4Immunoglobulin M (IgM)IBA
11/2018 - 01/2013
4Intravenous Immunoglobulins (IVIG)FDA Link
01/2018 - 07/2008
4Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
02/2015 - 05/2006
4Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
09/2012 - 08/2006
3Interleukin-1 (Interleukin 1)IBA
11/2022 - 06/2009
3CytokinesIBA
05/2022 - 01/2013
3Antiphospholipid AntibodiesIBA
05/2022 - 01/2018
3Peroxidase (Myeloperoxidase)IBA
01/2022 - 08/2015
3Infliximab (Remicade)FDA Link
10/2020 - 01/2016
3Creatine Kinase (Creatine Phosphokinase)IBA
01/2019 - 01/2009
3beta-cyclodextrin tetradecasulfate (CTDS)IBA
01/2018 - 01/2011
3Prednisone (Sone)FDA LinkGeneric
01/2018 - 01/2002
3Bosentan (Tracleer)FDA Link
01/2017 - 04/2006
3Adalimumab (Humira)FDA Link
01/2016 - 08/2011
3InterferonsIBA
03/2015 - 05/2010
3Rheumatoid FactorIBA
10/2011 - 03/2007
2CholesterolIBA
10/2022 - 12/2007
2LipidsIBA
10/2022 - 12/2007
2AnticoagulantsIBA
07/2022 - 07/2006
2Biological FactorsIBA
05/2022 - 06/2010
2EnzymesIBA
01/2022 - 07/2010

Therapy/Procedure

23Therapeutics
10/2022 - 12/2007
3Contraindications
10/2014 - 05/2009
2Off-Label Use
05/2022 - 02/2015